1. Home
  2. BRC vs AKRO Comparison

BRC vs AKRO Comparison

Compare BRC & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRC
  • AKRO
  • Stock Information
  • Founded
  • BRC 1914
  • AKRO 2017
  • Country
  • BRC United States
  • AKRO United States
  • Employees
  • BRC N/A
  • AKRO N/A
  • Industry
  • BRC Miscellaneous manufacturing industries
  • AKRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRC Consumer Discretionary
  • AKRO Health Care
  • Exchange
  • BRC Nasdaq
  • AKRO Nasdaq
  • Market Cap
  • BRC 3.4B
  • AKRO 3.6B
  • IPO Year
  • BRC 1984
  • AKRO 2019
  • Fundamental
  • Price
  • BRC $79.34
  • AKRO $44.03
  • Analyst Decision
  • BRC
  • AKRO Strong Buy
  • Analyst Count
  • BRC 0
  • AKRO 8
  • Target Price
  • BRC N/A
  • AKRO $80.38
  • AVG Volume (30 Days)
  • BRC 172.7K
  • AKRO 923.5K
  • Earning Date
  • BRC 09-04-2025
  • AKRO 11-07-2025
  • Dividend Yield
  • BRC 1.23%
  • AKRO N/A
  • EPS Growth
  • BRC N/A
  • AKRO N/A
  • EPS
  • BRC 3.92
  • AKRO N/A
  • Revenue
  • BRC $1,513,605,000.00
  • AKRO N/A
  • Revenue This Year
  • BRC $3.92
  • AKRO N/A
  • Revenue Next Year
  • BRC $4.01
  • AKRO N/A
  • P/E Ratio
  • BRC $19.98
  • AKRO N/A
  • Revenue Growth
  • BRC 12.84
  • AKRO N/A
  • 52 Week Low
  • BRC $62.70
  • AKRO $21.34
  • 52 Week High
  • BRC $84.03
  • AKRO $58.40
  • Technical
  • Relative Strength Index (RSI)
  • BRC 61.44
  • AKRO 39.02
  • Support Level
  • BRC $77.73
  • AKRO $42.56
  • Resistance Level
  • BRC $84.03
  • AKRO $46.18
  • Average True Range (ATR)
  • BRC 1.91
  • AKRO 1.75
  • MACD
  • BRC -0.06
  • AKRO -0.14
  • Stochastic Oscillator
  • BRC 56.12
  • AKRO 24.46

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: